ADXN Competitors & Alternatives

Compare Addex Therapeutics Ltd with similar stocks in the same industry

Biotechnology

ADXN

Main Stock
$4.06
-23.25%
Tradestie Score
33
Market Cap
$8.71M
Revenue Growth
-72.7%
Analyst Upside
+638.9%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Allosteric modulation discovery platform
Major Customers 2
Pharmaceutical partners Research institutions
Critical Suppliers 2
Contract research organizations Lab equipment suppliers
Direct Ecosystem Rivals 3

Top Competitors

221 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$10.36
-4.69%
$133.50M - 41 Compare
SRZN Surrozen, Inc. Common
$31.61
-0.19%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$29.54
-3.53%
$110.20M - 35 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.11
-3.42%
$84.52M - 47 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.84
-2.85%
$67.94M - 48 Compare
BCDA BioCardia, Inc. Common Stock
$0.83
+0.61%
$14.11M - 52 Compare
KZIA Kazia Therapeutics Limited American Depositary Shares
$6.62
-4.75%
$11.44M - 36 Compare
DRMA Dermata Therapeutics, Inc. Common Stock
$0.62
-6.01%
$3.50M - 41 Compare
AFIB AFIB
- - - - Compare
NMAD NMAD
$2.35
-36.49%
- - 39 Compare

Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 2834)

221 stocks in this industry